Pharmafile Logo
Pharmafocus logo
Advanced Search

Contract research news in brief

January 17, 2012
Manufacturing and Production, Research and Development AAIPharma and General Dynamics, Charles River Labs, Covance, ICON, ShangPharma

A round-up of developments in the contract research sector, including updates on Charles River Labs, ShangPharma, Icon, Covance, AAIPharma and …

News

Otsuka and UCB scale down collaboration

January 16, 2012
Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB

Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …

News

AstraZeneca looks for new partners to bolster pipeline

January 16, 2012
Business Services, Research and Development, Sales and Marketing AstraZeneca, BMS

AstraZeneca has used a recent healthcare conference in San Francisco to call for new drug development partners. Speaking at the …

News

NantWorks to invest $85.5m in former Pfizer plant

January 16, 2012
Manufacturing and Production Exubera, Nantworks, Pfizer

A former Pfizer manufacturing facility in Indiana, US, looks set for a new lease of life after technology company NantWorks …

News

Molecular Profiles starts work on clinical manufacturing facility

January 16, 2012
Manufacturing and Production Molecular Profiles

UK contract research and manufacturing services company Molecular Profiles has announced a £9 million investment in manufacturing facilities in the …

News

Xoma opts out of in-house manufacturing

January 16, 2012
Manufacturing and Production Xoma, manufacturing

US biotech Xoma has decided to rely on a contract manufacturing organisation for its Phase III and commercial production needs, …

News
andy_turner_web

Complete Worldwide appoints Andy Turner

January 16, 2012
Business Services, Medical Communications, Sales and Marketing Andy Turner, Complete Worldwide

Andy Turner has joined the medical communications firm Complete Worldwide, to head up a new capability they are building in …

Appointment

Europe wants regulatory reform over PIP implant scandal

January 16, 2012
Manufacturing and Production, Sales and Marketing EC, MHRA, PIP implants

The European Commission is seeking regulatory reform for class III medical devices after problems with French-made breast implants. The French …

News

Covidien appoints Mark Trudeau President of pharmaceuticals segment

January 16, 2012
Business Services, Manufacturing and Production, Sales and Marketing Covidien

Covidien has announced the appointment of Mark Trudeau as president of its Pharmaceuticals segment and a senior vice president of the company. …

Appointment

NICE says yes to Tasigna for resistant disease

January 13, 2012
Sales and Marketing BMS, Glivec, NICE, Novartis, Tasigna

NICE is recommending Novartis’ Tasigna for chronic myeloid leukaemia patients that can no longer use Glivec. In final guidance it …

News

AstraZeneca does data deal

January 13, 2012
Sales and Marketing AstraZeneca, IMS Health, data

AstraZeneca has signed a deal with an information company in a bid to improve the data it has on how …

News

Tracy Baker moves to MSI Consultancy

January 13, 2012
Medical Communications MSI Consultancy

MSI Consultancy has appointed former Novartis manager Tracy Baker as a new consultant. Tracy has over seven years of sales …

Appointment

Novartis to cut 2,000 US jobs

January 13, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts

Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …

News

Pharma unprepared for annus horribilis

January 12, 2012
Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma

A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …

News

Glide Pharma appoints Dr Ian Smith as its new chief executive

January 12, 2012
Business Services, Manufacturing and Production, Sales and Marketing

Glide Pharma, a firm focused on the needle-free administration of solid dose therapeutics and vaccines, has appointed Dr Ian Smith …

Appointment
NICE picture

NICE rejects Sanofi’s Jevtana

January 12, 2012
Sales and Marketing Jevtana, NICE, Sanofi, Zytiga

NICE is not recommending Sanofi’s prostate cancer drug Jevtana due to its high cost and questions over its safety. In …

News

Merck facility reborn as science park

January 11, 2012
Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland

A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …

News

NICE guidance to be enforced, says Lansley

January 11, 2012
Sales and Marketing NHS, NICE, PCTs, black lists, prescribing

Local NHS organisations will no longer be allowed to ‘ban’ drugs recommended by NICE, the health secretary has said.England’s primary …

News

Crisis in the boardroom: 2011’s most dramatic departures

January 11, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management

In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …

Feature

Janssen signs deal with rising star Forma

January 11, 2012
Research and Development Forma, Janssen, alliance

Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026